- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06278636
Laparoscopic Ultrasound Examination: Analysis of Feasibility (LUXA)
Laparoscopic Ultrasound Examination: Analysis of Feasibility and fEllows Surgeons' LEarning Curve in Minimally Invasive Gynecological Procedures
This is a prospective cohort study to assess the feasibility of the laparoscopic ultrasound examination, directly by surgeons, during minimally invasive gynaecological surgery.
The secondary aims are to examine the learning curve for laparoscopic ultrasound examination and the performance score in obtaining high quality ultrasound images of anatomical parameters by a team of 5 gynecological laparoscopic fellows. The patients' medical history and symptoms will also be recorded to define whether these clinical data can influence the failure rate. With advanced technology, the conventional workflow can be simplified by using laparoscopic ultrasound probes directly by surgeons, to utilize the hospital resources efficiently and to reduce operating times. In this regard, we would like to demonstrate that the application of laparoscopic examination is feasible and easy to learn by surgeons. This innovative technique could open up multiple diagnostic and therapeutic opportunities for the patient, providing potential clinical information useful to the surgeon.
Study Overview
Status
Intervention / Treatment
Detailed Description
The use of laparoscopic ultrasound is an evolving field with a potentially wide range of advantages that could facilitate complex gynecologic surgical procedures; increasing surgical safety by allowing the surgeon to see beyond the surface of the organ, visualizing anatomical structures and identifying, for example, retroperitoneal recurrences and benign or malignant pelvic lesions, even small and not visible laparoscopically, and consequently improving the surgical accuracy of tumor resection. (10) Gynecologists who are familiar with gynecological transvaginal ultrasound should be able to become proficient in identifying pelvic organs during surgical procedures in order to improve surgical accuracy, reduce complications, and ultimately improve patient care.
Nevertheless, this technique has been slow to be implemented in the clinical setting, perhaps due to the lack of a learning curve. Therefore, training gynecological surgical fellows in recognizing pelvic structures using laparoscopic probes is critical for allows them to use this tool in different application fields, providing them with an important advantage. The training of gynecological surgeons in the use of laparoscopic probes would provide an advantage in terms of surgical time, speeding up the procedures of recognition and removal of target lesions. In addition, by making surgeons autonomous in the operating theatre, the need for an additional ultrasound operator during surgery would be eliminated. These benefits would translate into a potential reduction in cost as well
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Floriana Mascilini
- Phone Number: 0630156399
- Email: floriana.mascilini@policlinicogemellli.it
Study Contact Backup
- Name: Maria Teresa Giudice
- Phone Number: 0630156399
- Email: mariateresa.giulia@guest.policlinicogemelli.it
Study Locations
-
-
-
Rome, Italy, 00168
- Recruiting
- Fondazione Policlinico Universitario Agostino Gemelli, IRCCS
-
Contact:
- Floriana Mascilini, Dr
-
Contact:
- Antonia Carla Testa, Prof
-
Principal Investigator:
- Floriana Mascilini
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Fellow surgeons with EFSUMB level 1 experience of ultrasound in gynecology.
- Women affected by gynecological pathologies undergoing elective laparoscopic surgery such as endometrial cancer, cervical cancer at early stage, or benign pathologies.
- All women will be required to sign written informed consent to enter the study.
Exclusion Criteria:
- Patients affected by gynaecological pathologies undergoing emergency surgeries.
- Refusal to sign written informed consent.
- Patients with previous hysterectomy or salpingo-oophorectomy.
- Uterus and adnexa not visualised at LPS examination.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
feasibility of the laparoscopic
Time Frame: 2 minutes
|
for to assess the feasibility of the laparoscopic ultrasound examination during minimally invasive gynaecological surgery, achievement of one ultrasound picture in maximum 120 seconds examination during minimally invasive gynaecological surgery, in terms of achievement of one ultrasound picture in maximum 120 seconds
|
2 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the learning curve of fellow surgeons
Time Frame: 5 minutes
|
To investigate the learning curve of fellow surgeons in obtaining skill competency by using laparoscopic probe
|
5 minutes
|
the performance of fellow surgeons
Time Frame: 30 minutes
|
To evaluate the performance of fellow surgeons in obtaining high-quality US images of anatomical parameters using expert assessment as the gold standard and in achieving a reduction in the operative time of laparoscopic probe use.
|
30 minutes
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 5745
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gynecologic Cancer
-
University of LouisvilleJames Graham Brown Cancer CenterCompleted
-
Shandong UniversityCompletedGynecologic Cancer | Gynecologic DiseaseChina
-
Washington University School of MedicineWashington University Department of Psychological and Brain SciencesTerminatedStage III Gynecologic Cancer | Stage IV Gynecologic CancerUnited States
-
Azienda Socio Sanitaria Territoriale degli Spedali...CompletedGynecologic Cancer | Surgery | Anesthesia | Hysterectomy | Gynecologic DiseaseItaly
-
Peking Union Medical College HospitalNot yet recruitingGynecologic Cancer
-
IRCCS Policlinico S. MatteoNot yet recruiting
-
Fudan UniversityGuangzhou Burning Rock Dx Co., Ltd.Recruiting
-
Fox Chase Cancer CenterCompleted
-
University Hospital, GenevaCompletedGynecologic CancerSwitzerland
-
Fudan UniversityGuangzhou Burning Rock Bioengineering Ltd.Active, not recruiting
Clinical Trials on Laparoscopi ultrasound examination
-
First Hospital of China Medical UniversityRecruitingCarotid Artery DiseasesChina
-
Brugmann University HospitalCompletedFetal MacrosomiaBelgium
-
University Hospital, Basel, SwitzerlandDePuy SynthesRecruitingArthroscopic Rotator Cuff Repair (ARCR)Switzerland
-
Peking Union Medical College HospitalUnknown
-
Shin Kong Wu Ho-Su Memorial HospitalCompleted
-
Umeå UniversityCompleted
-
University Hospital, ToursRecruiting
-
Unity Health TorontoWithdrawnDuctus ArteriosusCanada
-
Seoul National University HospitalCompletedCentral Line ComplicationKorea, Republic of
-
Baylor College of MedicineUniversity of Pittsburgh; Beijing Obstetrics and Gynecology Hospital; Samsung... and other collaboratorsCompletedBirth Weight | Fetal Growth Retardation | Fetal Macrosomia | Fetal Weight